Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01357525 · ClinicalTrials.gov registry record · NA
SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma
A NA study of Adenocarcinoma of the Pancreas, sponsored by David A. Clump, MD, PhD.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT01357525: Completed NA study of Adenocarcinoma of the Pancreas, sponsored by David A. Clump, MD, PhD.
NCT01357525 is a NA study of Adenocarcinoma of the Pancreas that has completed, run by David A. Clump, MD, PhD. The registered enrollment target is 50 participants, below the 85-participant average among 10 other Adenocarcinoma of the Pancreas trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01357525, a NA study of Adenocarcinoma of the Pancreas, has completed, sponsored by David A. Clump, MD, PhD.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The current study seeks to further investigate the impact of Stereotactic Body Radiation Therapy following pancreatic resection with a close or positive margin. The investigators hope to improve local control, and through the use of a shortened treatment schedule, allow patients to begin systemic therapy earlier.
Primary Outcome
Percentage of patients that did not experience progressive disease (PD) in the target lesion. Death or development of distant disease was not regarded as an event. For patients that underwent surgical resection, local progression was defined as disease recurrence detected on follow-up imaging (CT or FDG-PET/CT) that is located within the SBRT target volume.
Conditions Studied
Interventions
- RADIATION Stereotactic Body Radiation Therapy (SBRT)
Study Locations (1)
Pennsylvania
- UPMC Hillman Cancer Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-02-06 |
| Est. Completion | 2018-06-01 |
| Phase | NA |
What the finished NCT01357525 record still lists
NCT01357525 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 85-participant average among 10 other Adenocarcinoma of the Pancreas trials with a reported enrollment target (41% lower).
The record links to 1 condition, with Adenocarcinoma of the Pancreas appearing as the primary indexed condition, and to 1 intervention - of which Stereotactic Body Radiation Therapy (SBRT) is the first listed.
NCT01357525 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01357525 about?
NCT01357525 is a clinical study titled "SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma". The current study seeks to further investigate the impact of Stereotactic Body Radiation Therapy following pancreatic resection with a close or positive margin. The investigators hope to improve local control, and through the use of a shortened treatment schedule, allow patients to begin systemic th...
What is the current status of trial NCT01357525?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2013-02-06. Estimated completion is 2018-06-01.
What conditions does trial NCT01357525 study?
This clinical trial studies the following conditions: Adenocarcinoma of the Pancreas.
What interventions are being tested in trial NCT01357525?
The interventions under investigation include: Stereotactic Body Radiation Therapy (SBRT) (RADIATION).
Who is sponsoring clinical trial NCT01357525?
This trial is sponsored by David A. Clump, MD, PhD, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01357525 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adenocarcinoma of the Pancreas
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01357525's enrollment target sits among peer trials
50 2nd of 10 the highest of 10 other Adenocarcinoma of the Pancreas trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Adenocarcinoma of the Pancreas trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma
RECRUITING · Phase 1
-
Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma
RECRUITING · Phase 2
-
Gamma Secretase Inhibitor RO4929097 in Previously Treated Metastatic Pancreas Cancer
COMPLETED · Phase 2
-
Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
COMPLETED · Phase 3
-
Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer
COMPLETED · Phase 2
-
Perioperative Therapy for Resectable Pancreatic Cancer
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI